Cover Caption
About the cover: BayCysLT2 selectively antagonizes the human CysLT2 receptor calcium responses. See the article by Ni et al. on page 768 of this issue.
In this issue
Jump to
- Highlighted Papers
- Behavioral Pharmacology
- Cardiovascular
- Cellular and Molecular
- Chemotherapy, Antibiotics, and Gene Therapy
- Drug Discovery and Translational Medicine
- Endocrine and Diabetes
- Gastrointestinal, Hepatic, Pulmonary, and Renal
- Inflammation, Immunopharmacology, and Asthma
- Metabolism, Transport, and Pharmacogenomics
- Erratum
